UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

Annals of oncology, 2017-11, Vol.28 (11), p.2866-2873

2017

Volltextzugriff (PDF)

80P Blood tumor mutational burden (bTMB) and efficacy of immune checkpoint inhibitors (ICIs) in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN

Annals of oncology, 2021-09, Vol.32, p.S390-S391

2021

Volltextzugriff (PDF)

Inductive, Scaffold-Based, Regenerative Medicine Approach to Reconstruction of the Temporomandibular Joint Disk

Journal of oral and maxillofacial surgery, 2012-11, Vol.70 (11), p.2656-2668

2012

Volltextzugriff (PDF)

HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study

Urologic oncology, 2023-12, Vol.41 (12), p.486.e15-486.e23

2023

Volltextzugriff (PDF)

Pan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors

Annals of oncology, 2018-10, Vol.29, p.viii17-viii17

2018

Volltextzugriff (PDF)

Landscape of RAF1 fusions in solid tumors and therapeutic utility of sorafenib

European journal of cancer (1990), 2016-12, Vol.69, p.S142-S142

2016

Volltextzugriff (PDF)

573P Panorama of genomic RET alterations (GA) in the major subtypes of thyroid carcinomas (TC)

Annals of oncology, 2021-09, Vol.32, p.S623-S623

2021

Volltextzugriff (PDF)

Anaplastic thyroid carcinoma: a genome-based search for new targeted therapy options

American journal of clinical pathology, 2024-10, Vol.162 (Supplement_1), p.S68-S69

2024

Volltextzugriff (PDF)

Next-generation sequencing (NGS) of anaplastic thyroid carcinoma identifies unreported mutations in 25 recurring genes

American journal of clinical pathology, 2024-10, Vol.162 (Supplement_1), p.S68-S68

2024

Volltextzugriff (PDF)

Familial adenomatous polyposis gene MUTYH mutations are identified in anaplastic thyroid carcinoma

American journal of clinical pathology, 2024-10, Vol.162 (Supplement_1), p.S124-S124

2024

Volltextzugriff (PDF)

Expanding the use of targeted therapy for Urothelial Bladder Cancer (UBC): Non-FGFR3 Receptor Tyrosine Kinase (RTK) Gene Rearrangements (ReAr) and Fusions (Fus)

European urology, 2022-02, Vol.81, p.S1342-S1343

2022

Volltextzugriff (PDF)

CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS)

European urology, 2023-02, Vol.83, p.S774

2023

Volltextzugriff (PDF)

A0542 - CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS)

European urology, 2023-02, Vol.83, p.S774-S774

2023

Volltextzugriff (PDF)

Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues

Toxicology letters, 2005-07, Vol.158 (1), p.50-60

2005

Volltextzugriff (PDF)

P1.16-04 Real World Experience of Using Comprehensive Genomic Profiling of Plasma Circulating Tumor DNA

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S586-S587

2019

Volltextzugriff (PDF)

Methylthioadenosine Phosphorylase (MTAP) deletion is more common in Sarcomatoid (srcRCC) than in clear cell Renal Cell Carcinoma (ccRCC)

European urology, 2021-06, Vol.79, p.S868-S869

2021

Volltextzugriff (PDF)

OA 12.08 Genomic Analysis of Non-Small Cell Lung Cancer (NSCLC) Cases with Focal and Non-Focal MET Amplification

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1778-S1779

2017

Volltextzugriff (PDF)

MA16.05 MET Kinase Domain Rearrangements (KDRE) in Non-Small Cell Lung Cancer (NSCLC) Identified Through Comprehensive Genomic Profiling (CGP)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S412-S412

2018

Volltextzugriff (PDF)

58PDPan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

P1.14-04 Final Results of the Prospective Genomics of Young Lung Cancer (GYLC), an Addario Lung Cancer Medical Institute Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S553-S553

2019

Volltextzugriff (PDF)

1167PClassification of esthesioneuroblastoma (ENB) based on chromosome (chr) arm gain and loss (CNA) in the setting of a hypomutated genomic landscape

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

The Use of a Xenogenic Extracellular Matrix Scaffold for Guided Reconstruction of the Temporomandibular Joint Meniscus in a Canine Model

Journal of oral and maxillofacial surgery, 2009, Vol.67 (9), p.33-34

Pavlick, Matthew D., DDS, MD

2009

Volltextzugriff (PDF)

2039PDriving solo? Investigation into collaborating mutations in SDH-deficient neoplasia

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Genomic profiling of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and oncogenic rearrangements (RE) across diverse tumor types

Annals of oncology, 2017-09, Vol.28, p.v595-v595

2017

Volltextzugriff (PDF)

435 - Landscape of RAF1 fusions in solid tumors and therapeutic utility of sorafenib

European journal of cancer (1990), 2016-12, Vol.69, p.S142-S142

2016

Volltextzugriff (PDF)

1 – 25 von 258

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(239)

Publikationsform

Artikel
(257)
Tagungsberichte
(1)

Sprache

Englisch
(256)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

80P Blood tumor mutational burden (bTMB) and efficacy of immune checkpoint inhibitors (ICIs) in advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN

Inductive, Scaffold-Based, Regenerative Medicine Approach to Reconstruction of the Temporomandibular Joint Disk

HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study

Pan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors

Landscape of RAF1 fusions in solid tumors and therapeutic utility of sorafenib

573P Panorama of genomic RET alterations (GA) in the major subtypes of thyroid carcinomas (TC)

Anaplastic thyroid carcinoma: a genome-based search for new targeted therapy options

Next-generation sequencing (NGS) of anaplastic thyroid carcinoma identifies unreported mutations in 25 recurring genes

Familial adenomatous polyposis gene MUTYH mutations are identified in anaplastic thyroid carcinoma

Expanding the use of targeted therapy for Urothelial Bladder Cancer (UBC): Non-FGFR3 Receptor Tyrosine Kinase (RTK) Gene Rearrangements (ReAr) and Fusions (Fus)

CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS)

A0542 - CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS)

Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues

P1.16-04 Real World Experience of Using Comprehensive Genomic Profiling of Plasma Circulating Tumor DNA

Methylthioadenosine Phosphorylase (MTAP) deletion is more common in Sarcomatoid (srcRCC) than in clear cell Renal Cell Carcinoma (ccRCC)

OA 12.08 Genomic Analysis of Non-Small Cell Lung Cancer (NSCLC) Cases with Focal and Non-Focal MET Amplification

MA16.05 MET Kinase Domain Rearrangements (KDRE) in Non-Small Cell Lung Cancer (NSCLC) Identified Through Comprehensive Genomic Profiling (CGP)

58PDPan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors

P1.14-04 Final Results of the Prospective Genomics of Young Lung Cancer (GYLC), an Addario Lung Cancer Medical Institute Study

1167PClassification of esthesioneuroblastoma (ENB) based on chromosome (chr) arm gain and loss (CNA) in the setting of a hypomutated genomic landscape

The Use of a Xenogenic Extracellular Matrix Scaffold for Guided Reconstruction of the Temporomandibular Joint Meniscus in a Canine Model

2039PDriving solo? Investigation into collaborating mutations in SDH-deficient neoplasia

Genomic profiling of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and oncogenic rearrangements (RE) across diverse tumor types

435 - Landscape of RAF1 fusions in solid tumors and therapeutic utility of sorafenib

Suchergebnisse filtern